Correvio Pharma heart drug Brinavess fails to get USFDA nod Medical Dialogues Bureau27 Dec 2019 9:22 AM ISTIn the so-called complete response letter, the USFDA stated that while the submitted data provide substantial evidence of the drug's effectiveness,...
Lannett gets USFDA nod for Butalbital, Acetaminophen and Caffeine Capsules Medical Dialogues Bureau27 Dec 2019 9:20 AM ISTThe two dosage strengths of BAC Capsules, have a combined estimated IQVIA market value of approximately $68.6 million for the 12 months ending October...
Dishman Carbogen shares rise by 9 pc after I-T department conducts search at offices Medical Dialogues Bureau26 Dec 2019 4:29 PM ISTAhmedabad: The share price of Dishman Carbogen Amcis rose by over 9 per cent on Thursday after officials of the Income Tax Department conducted search...
Allergan signs $750 million settlement with purchasers of Alzheimer's drug Namenda Medical Dialogues Bureau26 Dec 2019 2:24 PM ISTNEW YORK: Purchasers of Allergan Plc's Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker...
Piramal Enterprises to raise Rs 2,750 crore by issuing bonds on private placement basis. Medical Dialogues Bureau26 Dec 2019 2:23 PM ISTMumbai: Piramal Enterprises said on Wednesday that it will raise up to Rs 2,750 crore by issuing bonds on private placement basis."A meeting of the...
Eurolife Healthcare acquires intravenous infusion business of Teva, Hungary Medical Dialogues Bureau26 Dec 2019 9:23 AM ISTNew Delhi: Drug firm Eurolife Healthcare on Tuesday said it has completed the acquisition of intravenous (IV) infusion business of Teva Pharmaceutical...
Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval Medical Dialogues Bureau25 Dec 2019 9:55 AM ISTThe USFDA approved Travoprost Ophthalmic Solution is a generic equivalent to Alcon Pharmaceuticals' Travatan Ophthalmic Solution, Alembic...
Granules India gets USFDA nod for allergy treatment drug Loratadine Medical Dialogues Bureau25 Dec 2019 9:50 AM IST"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine...
Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal Medical Dialogues Bureau25 Dec 2019 9:32 AM ISTRoche will make an upfront payment of $750 million in cash and take a $400 million stake in Sarepta, priced at $158.59 per share, a premium of about...
Merck KEYTRUDA gets Japanese nod for head, neck cancer Medical Dialogues Bureau25 Dec 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, recently announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received new...
Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease Farhat Nasim25 Dec 2019 9:15 AM ISTNew Delhi: Sunovion Pharmaceuticals Inc. (Sunovion) recently announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug...
Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin Medical Dialogues Bureau24 Dec 2019 12:05 PM ISTUnder the sub-licensing agreement, Mankind will market diabetes drug Remogliflozin Etabonate under its own trademark while Glenmark will manufacture...
